ORECCHIONI, STEFANIA
 Distribuzione geografica
Continente #
AS - Asia 40
NA - Nord America 32
EU - Europa 24
SA - Sud America 5
AF - Africa 3
Totale 104
Nazione #
US - Stati Uniti d'America 31
CN - Cina 24
IE - Irlanda 9
SG - Singapore 9
DE - Germania 6
BR - Brasile 4
FI - Finlandia 3
RU - Federazione Russa 3
VN - Vietnam 3
HK - Hong Kong 2
EC - Ecuador 1
ET - Etiopia 1
FR - Francia 1
GB - Regno Unito 1
JO - Giordania 1
KE - Kenya 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
ZA - Sudafrica 1
Totale 104
Città #
Dublin 9
Chandler 7
Beijing 6
Singapore 6
Ashburn 3
Helsinki 3
Munich 3
Nanjing 3
Changsha 2
Hong Kong 2
Nanchang 2
New York 2
San Jose 2
Shanghai 2
Addis Ababa 1
Amman 1
Boardman 1
Carolina 1
Corumbá 1
Frankfurt am Main 1
Hangzhou 1
Hanoi 1
Hebei 1
Itajaí 1
Jacksonville 1
Johannesburg 1
Lauterbourg 1
Lawrence 1
Los Angeles 1
Lấp Vò 1
Medford 1
Moscow 1
Nairobi 1
Pittsburgh 1
Poplar 1
Porto Alegre 1
Princeton 1
Quận Một 1
Redwood City 1
São Paulo 1
Tianjin 1
Wilmington 1
Zhengzhou 1
Zhongshan 1
Totale 82
Nome #
Stromal Cell-Derived Factor-1alpha Promotes Endothelial Colony-Forming Cell Migration Through the Ca2+-Dependent Activation of the Extracellular Signal-Regulated Kinase 1/2 and Phosphoinositide 3-Kinase/AKT Pathways 104
Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer 2
Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens 2
A "two-hit" (chemo)therapy to improve checkpoint inhibition in cancer 2
A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies 1
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients 1
Totale 112
Categoria #
all - tutte 630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 1 3
2022/202320 3 2 0 1 3 1 0 0 10 0 0 0
2023/20248 1 3 0 0 1 2 0 0 0 1 0 0
2024/202515 1 1 0 0 0 1 0 1 4 0 2 5
2025/202644 6 0 3 3 7 3 4 3 3 4 0 8
Totale 112